Dolphin Vision

Air Fresheners innovation - Neutralising Airborne Viruses with Natural Blends

Health Tech & Life Sciences
Active
Pre-Seed Jerusalem, Israel Founded 2018
Last updated 2026-06-18
Total raised
$79K
Last: 2018-03
Stage
Pre-Seed
Founded
2018
Headcount
5
HQ
Jerusalem, Israel
Sector
Health Tech & Life Sciences

About

Dolphin Vision provides advanced air freshener systems designed to neutralise airborne viral pathogens in commercial and public indoor spaces. Its flagship product, Arothera, is a barely noticeable device that utilises gentle therapeutic diffusion of all-natural, plant-based aroma blends. This proprietary combination of natural ingredients actively destroys aerobic pathogens in the air, offering a continuous method of facility protection against infection. The system targets a wide range of common airborne diseases, including Influenza, COVID-19, Avian Flu, and Tuberculosis, significantly reducing the risk of illness. By proactively neutralising viruses and providing a pleasant, fragrant environment, Dolphin Vision enables employees and clients to feel safe returning to offices and clinics. The solution is efficient and scalable, with large-scale modules capable of covering extensive facilities such as open-plan offices, hotels, and transit hubs.

Funding history · 2 rounds · $79K total

Date unknown

Q&A

What is Dolphin Vision's primary focus?
Dolphin Vision specializes in advanced air freshener systems designed to neutralize airborne viral pathogens in commercial and public indoor spaces.
What is Dolphin Vision's flagship product?
Dolphin Vision's flagship product is Arothera, a device that uses gentle therapeutic diffusion of all-natural, plant-based aroma blends to destroy aerobic pathogens in the air.
What types of airborne diseases does Dolphin Vision's system target?
Dolphin Vision's system targets a wide range of common airborne diseases, including Influenza, COVID-19, Avian Flu, and Tuberculosis.
When was Dolphin Vision founded?
Dolphin Vision was founded in April 2018.
How many employees does Dolphin Vision have?
Dolphin Vision has 1-10 employees.
What is Dolphin Vision's total funding raised to date?
Dolphin Vision has raised a total of $78,500.
Who are the founders of Dolphin Vision?
The founders of Dolphin Vision are Gennady Simanovsky (Founder & CEO) and Michael Farber (CTO). Brian Tervil was also a co-founder but is no longer with the company.
What is Dolphin Vision's current funding stage?
Dolphin Vision is currently in the Pre-Seed funding stage.
Which investors participated in Dolphin Vision's March 2018 funding round?
In March 2018, Dolphin Vision received funding from Shay Maoz and Gido van Praag.

Team · 3

Founder · Founder & CEO
LinkedIn ↗
Founder · Co-founder (No longer with the company)
LinkedIn ↗
Founder · CTO
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical Biotechnology
Technologies
Materials & Substances
Target customers
Food Retail & ConsumptionDefense, Safety & SecurityNational SecurityTransportation & LogisticsTransportation InfrastructureReal Estate & ConstructionManagementCommercialGovernment & CityCommerce & Retail
Business model
B2GB2B

Highlights

1 PatentsVerified

Tags

filtration-and-purificationcommercial-sitesmanufacturing-facilitiestransportationautomotiveairportsdefensereal-estateclinics
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)